GlassScriptPhysician profile
Ahamed Khalyfa
NPI 1336777879
$3,010.13
in general payments reported to CMS, 2019-2025
7 companies · $1,882 in 2025
The $1,882 reported for 2025 was more than what 77% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.10 · 2024: $1,088 · 2025: $1,882.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,707 · Food and Beverage: $875 · Grant: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,707.31 |
| Food and Beverage | $874.62 |
| Grant | $387.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wilson Cook Medical Incorporated | $1,182.21 | 2025 | Echotip Insight, Hemospray |
| Pinnacle Biologics, INC | $1,002.05 | 2024 | Photofrin |
| Cook Incorporated | $387.10 | 2025 | |
| Cook Medical LLC | $186.19 | 2025 | Fusion, Echotip Insight |
| Janssen Biotech, INC. | $126.00 | 2025 | Tremfya |
| Boston Scientific Corporation | $85.48 | 2024 | Wallflex Duodenal |
| Lilly USA, LLC | $41.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahamed Khalyfa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.